250 related articles for article (PubMed ID: 33854494)
1. Adipocyte Oncostatin Receptor Regulates Adipose Tissue Homeostasis and Inflammation.
Sanchez-Infantes D; Stephens JM
Front Immunol; 2020; 11():612013. PubMed ID: 33854494
[TBL] [Abstract][Full Text] [Related]
2. Loss of Oncostatin M Signaling in Adipocytes Induces Insulin Resistance and Adipose Tissue Inflammation in Vivo.
Elks CM; Zhao P; Grant RW; Hang H; Bailey JL; Burk DH; McNulty MA; Mynatt RL; Stephens JM
J Biol Chem; 2016 Aug; 291(33):17066-76. PubMed ID: 27325693
[TBL] [Abstract][Full Text] [Related]
3. Lack of oncostatin M receptor β leads to adipose tissue inflammation and insulin resistance by switching macrophage phenotype.
Komori T; Tanaka M; Senba E; Miyajima A; Morikawa Y
J Biol Chem; 2013 Jul; 288(30):21861-75. PubMed ID: 23760275
[TBL] [Abstract][Full Text] [Related]
4. Oncostatin m is produced in adipose tissue and is regulated in conditions of obesity and type 2 diabetes.
Sanchez-Infantes D; White UA; Elks CM; Morrison RF; Gimble JM; Considine RV; Ferrante AW; Ravussin E; Stephens JM
J Clin Endocrinol Metab; 2014 Feb; 99(2):E217-25. PubMed ID: 24297795
[TBL] [Abstract][Full Text] [Related]
5. Deficiency of oncostatin M receptor β (OSMRβ) exacerbates high-fat diet-induced obesity and related metabolic disorders in mice.
Komori T; Tanaka M; Senba E; Miyajima A; Morikawa Y
J Biol Chem; 2014 May; 289(20):13821-37. PubMed ID: 24695736
[TBL] [Abstract][Full Text] [Related]
6. Genetic Deficiency of TRAF5 Promotes Adipose Tissue Inflammation and Aggravates Diet-Induced Obesity in Mice.
Gissler MC; Anto-Michel N; Pennig J; Scherrer P; Li X; Marchini T; Pfeiffer K; Härdtner C; Abogunloko T; Mwinyella T; Sol Mitre L; Spiga L; Koentges C; Smolka C; von Elverfeldt D; Hoppe N; Stachon P; Dufner B; Heidt T; Piepenburg S; Hilgendorf I; Bjune JI; Dankel SN; Mellgren G; Seifert G; Eisenhardt SU; Bugger H; von Zur Muhlen C; Bode C; Zirlik A; Wolf D; Willecke F
Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2563-2574. PubMed ID: 34348490
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine kinase 1 regulates adipose proinflammatory responses and insulin resistance.
Wang J; Badeanlou L; Bielawski J; Ciaraldi TP; Samad F
Am J Physiol Endocrinol Metab; 2014 Apr; 306(7):E756-68. PubMed ID: 24473437
[TBL] [Abstract][Full Text] [Related]
8. Oncostatin M Induces Lipolysis and Suppresses Insulin Response in 3T3-L1 Adipocytes.
Bailey JL; Hang H; Boudreau A; Elks CM
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563078
[TBL] [Abstract][Full Text] [Related]
9. Oncostatin M in the development of metabolic syndrome and its potential as a novel therapeutic target.
Komori T; Morikawa Y
Anat Sci Int; 2018 Mar; 93(2):169-176. PubMed ID: 29103176
[TBL] [Abstract][Full Text] [Related]
10. A Role for Oncostatin M in the Impairment of Glucose Homeostasis in Obesity.
Piquer-Garcia I; Campderros L; Taxerås SD; Gavaldà-Navarro A; Pardo R; Vila M; Pellitero S; Martínez E; Tarascó J; Moreno P; Villarroya J; Cereijo R; González L; Reyes M; Rodriguez-Fernández S; Vives-Pi M; Lerin C; Elks CM; Stephens JM; Puig-Domingo M; Villarroya F; Villena JA; Sánchez-Infantes D
J Clin Endocrinol Metab; 2020 Mar; 105(3):e337-48. PubMed ID: 31606738
[TBL] [Abstract][Full Text] [Related]
11. Adipocyte Ceramides-The Nexus of Inflammation and Metabolic Disease.
Chaurasia B; Talbot CL; Summers SA
Front Immunol; 2020; 11():576347. PubMed ID: 33072120
[TBL] [Abstract][Full Text] [Related]
12. Obesity-induced DNA released from adipocytes stimulates chronic adipose tissue inflammation and insulin resistance.
Nishimoto S; Fukuda D; Higashikuni Y; Tanaka K; Hirata Y; Murata C; Kim-Kaneyama JR; Sato F; Bando M; Yagi S; Soeki T; Hayashi T; Imoto I; Sakaue H; Shimabukuro M; Sata M
Sci Adv; 2016 Mar; 2(3):e1501332. PubMed ID: 27051864
[TBL] [Abstract][Full Text] [Related]
13. Oncostatin M is a potential agent for the treatment of obesity and related metabolic disorders: a study in mice.
Komori T; Tanaka M; Furuta H; Akamizu T; Miyajima A; Morikawa Y
Diabetologia; 2015 Aug; 58(8):1868-76. PubMed ID: 25972231
[TBL] [Abstract][Full Text] [Related]
14. Amyloid precursor protein expression is upregulated in adipocytes in obesity.
Lee YH; Tharp WG; Maple RL; Nair S; Permana PA; Pratley RE
Obesity (Silver Spring); 2008 Jul; 16(7):1493-500. PubMed ID: 18483477
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory cytokines interleukin-6 and oncostatin m induce plasminogen activator inhibitor-1 in human adipose tissue.
Rega G; Kaun C; Weiss TW; Demyanets S; Zorn G; Kastl SP; Steiner S; Seidinger D; Kopp CW; Frey M; Roehle R; Maurer G; Huber K; Wojta J
Circulation; 2005 Apr; 111(15):1938-45. PubMed ID: 15837947
[TBL] [Abstract][Full Text] [Related]
16. Oncostatin M suppresses browning of white adipocytes via gp130-STAT3 signaling.
van Krieken PP; Odermatt TS; Borsigova M; Blüher M; Wueest S; Konrad D
Mol Metab; 2021 Dec; 54():101341. PubMed ID: 34547509
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor is induced by the inflammatory cytokines interleukin-6 and oncostatin m in human adipose tissue in vitro and in murine adipose tissue in vivo.
Rega G; Kaun C; Demyanets S; Pfaffenberger S; Rychli K; Hohensinner PJ; Kastl SP; Speidl WS; Weiss TW; Breuss JM; Furnkranz A; Uhrin P; Zaujec J; Zilberfarb V; Frey M; Roehle R; Maurer G; Huber K; Wojta J
Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1587-95. PubMed ID: 17525365
[TBL] [Abstract][Full Text] [Related]
18. The role of infiltrating immune cells in dysfunctional adipose tissue.
Guzik TJ; Skiba DS; Touyz RM; Harrison DG
Cardiovasc Res; 2017 Jul; 113(9):1009-1023. PubMed ID: 28838042
[TBL] [Abstract][Full Text] [Related]
19. Thalidomide controls adipose tissue inflammation associated with high-fat diet-induced obesity in mice.
Nakamitsu PZ; Compri CM; de Fraia Pinto L; Gotardo ÉM; de Oliveira CC; Ribeiro ML; Pedrazzoli J; Gambero A
Endocr Metab Immune Disord Drug Targets; 2015; 15(2):151-8. PubMed ID: 25441253
[TBL] [Abstract][Full Text] [Related]
20. Adipose Tissue Dysfunction Occurs Independently of Obesity in Adipocyte-Specific Oncostatin Receptor Knockout Mice.
Stephens JM; Bailey JL; Hang H; Rittell V; Dietrich MA; Mynatt RL; Elks CM
Obesity (Silver Spring); 2018 Sep; 26(9):1439-1447. PubMed ID: 30226002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
